Neil has advised a number of top tier private equity funds and financial sponsors including Brookfield Private Equity, CVC Capital Partners, 3i, a global alternative investment management firm, Partners Group, Warburg Pincus, Exponent, ICG Private Equity, Stonepeak, Fiera Capital, Advent, Triton, Providence Equity Partners, Hg Capital and PAI.
Neil is recognised as one of the leading sponsor side leveraged finance lawyers in the market and has been profiled as a rising star by Legal Business in their article Banking and finance focus: Back to the future, and named in the 40 under 40 Rising Stars in Private Equity (Legal Week 2019). He also led the teams that won Loan Deal of the Year (Ethypharm), High Yield Deal of the Year (Modulaire) at the IFLR Europe Awards, 2022 and Loan Deal of the Year (Action) at the IFLR Awards, 2024. Clients say “Neil is excellent - he is one of the smartest lawyers out there, extremely commercial and well versed on the product level and detail” and “Neil Sinha is one of the best in the business on the leveraged finance side, you are always comfortable he will get you the best terms.” Chambers UK.
Neil is named as leading individual for acquisition finance in Legal 500 (2024), and is ranked for Banking & Finance: Big-Ticket UK, Chambers 2025 guide.
